<DOC>
	<DOCNO>NCT01895543</DOCNO>
	<brief_summary>Safety Tolerability Extension Trial Patients Chronic Idiopathic Constipation ( CIC )</brief_summary>
	<brief_title>Safety Tolerability Extension Trial Patients With Chronic Idiopathic Constipation</brief_title>
	<detailed_description>This Phase 3 multicenter , open-label , safety tolerability extension trial 10 mg elobixibat daily , possibility dose adjustment 5 mg daily , 52-week Treatment Period patient CIC . A dose adjustment 5 mg/day allow remainder trial patient report unacceptable treatment-related diarrhoea occur within first four week treatment . The trial enrol patient two lead-in , double-blind efficacy trial ( trial code NCT01827592 NCT01833065 ) .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>Has complete doubleblind treatment either leadin efficacy trial , 000079 000080 . The patient report understood sign Informed Consent Form ( ICF ) willing comply trial visit assessment . The patient agree refrain make new , major lifestyle change may affect CIC symptom ( i.e. , start new diet , change exercise plan ) time sign ICF last trial visit . The patient withdrawn/discontinued 000079 000080 trial . The patient willing abide restriction intake prohibited medication . Women childbearing potential ( define , purpose trial , females postpuberty , postmenopausal â‰¥2 year , surgically sterile ) positive urine pregnancy test Visit 1 , agree use one follow method birth control day sign ICF 30 day final dose trial drug exclude : 1 . Transdermal patch 2 . Established use oral , injected implant hormonal method contraception 3 . Placement intrauterine device ( IUD ) intrauterine system ( IUS ) . 4 . Barrier method contraception : Condom Occlusive cap ( diaphragm cervical/vault cap ) spermicidal foam/gel/film/cream/suppository . 5 . Male sterilisation ( appropriate postvasectomy documentation absence sperm ejaculate ) . 6 . True sexual abstinence : line prefer usual lifestyle patient . The patient consider Investigator unsuitable participate trial reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>